ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,194Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 1006

$981K Total Retail Price of All Prescriptions

Rank: 42 out of 1006

677 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 677 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 677 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 14,382 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 721 581 1 2
FUROSEMIDE 587 538 2 6
AMLODIPINE BESYLATE 571 567 3 4
LISINOPRIL 559 491 4 3
OMEPRAZOLE 554 443 5 9
METOPROLOL TARTRATE 510 451 6 7
SIMVASTATIN 497 414 7 1
WARFARIN SODIUM 453 438 8 8
GABAPENTIN 368 332 9 20
ATORVASTATIN CALCIUM 243 194 10 5
HYDROCHLOROTHIAZIDE 232 204 11 11
RISPERIDONE 226 135 12 40
METOPROLOL SUCCINATE 219 177 13 12
QUETIAPINE FUMARATE 217 191 14 45
TRAZODONE HCL 216 172 15 21
POTASSIUM CHLORIDE 201 181 16 30
SERTRALINE HCL 197 177 17 19
CITALOPRAM HBR 189 153 18 24
GLIPIZIDE 186 173 19 69
METFORMIN HCL 167 144 20 10
DOXYCYCLINE HYCLATE 142 90 21 130
ZOLPIDEM TARTRATE 139 119 22 14
HYDROCODONE-ACETAMINOPHEN 137 102 S3 23 25
NAPROXEN 136 101 24 121
ESCITALOPRAM OXALATE 136 108 24 27
CYMBALTA 133 119 26 41
ATENOLOL 132 120 27 13
IPRATROPIUM-ALBUTEROL 129 116 28 73
NAMENDA 127 127 29 34
PREDNISONE 126 103 30 33
TRAMADOL HCL 126 110 30 35
FLUTICASONE PROPIONATE 122 98 32 55
AZITHROMYCIN 119 110 33 39
FLUOXETINE HCL 115 111 34 85
ADVAIR DISKUS 115 94 34 37
RANITIDINE HCL 112 105 36 63
ALLOPURINOL 109 82 37 31
DIGOXIN 107 107 38 52
NEXIUM 107 92 38 28
OLANZAPINE 107 63 38 68
DIOVAN 99 99 41 16
MECLIZINE HCL 98 80 42 137
BENZTROPINE MESYLATE 97 45 R 43 106
IBUPROFEN 97 73 43 114
MIRTAZAPINE 95 82 45 26
FINASTERIDE 95 95 45 76
TAMSULOSIN HCL 93 88 47 23
HALOPERIDOL 91 79 48 129
DONEPEZIL HCL 88 65 49 17
METHYLPREDNISOLONE 87 82 50 148
PROAIR HFA 85 61 51 64
ABILIFY 83 51 52 102
SEROQUEL 81 70 53 97
LOSARTAN POTASSIUM 80 76 54 22
AMOX TR-POTASSIUM CLAVULANATE 79 72 55 123
LANTUS 77 62 56 43
LIPITOR 74 61 57 47
FENTANYL 74 62 S2 57 74
SPIRIVA 73 54 59 48
PRAVASTATIN SODIUM 71 71 60 15
PANTOPRAZOLE SODIUM 71 69 60 32
METHOCARBAMOL 70 47 R 62 225
OXYCODONE-ACETAMINOPHEN 66 48 S2 63 57
DIVALPROEX SODIUM 66 41 63 53
KLOR-CON M20 64 48 65 70
CARVEDILOL 64 64 65 36
HYDROCORTISONE VALERATE 63 58 67 343
LATANOPROST 61 48 68 192
KLOR-CON 10 61 49 68 226
OXYBUTYNIN CHLORIDE ER 60 48 70 92
METOCLOPRAMIDE HCL 59 54 71 134
ACTOS 59 58 71 89
ALENDRONATE SODIUM 58 40 73 29
CLOPIDOGREL 58 52 73 46
ISOSORBIDE MONONITRATE ER 57 57 75 59
PLAVIX 57 53 75 61
LAMOTRIGINE 56 0 77 119
CIPROFLOXACIN HCL 55 53 78 75
CELEBREX 54 50 79 90
LEVOFLOXACIN 54 47 79 96
OXYCODONE HCL 53 32 S2 81 54
METOLAZONE 52 51 82 210
NIFEDIPINE ER 51 43 83 166
INSULIN SYRINGE 51 46 83 122
AMOXICILLIN 51 47 83 156
SPIRONOLACTONE 50 34 86 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.